Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant GPIIIa and/or variant BPIIb allele

US Patent 6368797 · Granted Apr 9, 2002

Estimated economic value: $752,000

Assignee

Inventors

View full patent text on Google Patents →